Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Domiciliary Nasal High Flow (NHF) Therapy Improve Patient Outcomes in Chronic Hypercapnic Respiratory Failure (CHRF) in the United Kingdom (UK): A Pre and Post Interventional Study

NCT05167201 is registered in ClinicalTrials.gov with Royal Free Hospital NHS Foundation Trust as lead sponsor.

NCT NCT05167201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05167201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Domiciliary Nasal High Flow (NHF) Therapy Improve Patient Outcomes in Chronic Hypercapnic Respiratory Failure (CHRF) in the United Kingdom (UK): A Pre and Post Interventional Study
Lead sponsor
Royal Free Hospital NHS Foundation Trust
Phase
Not applicable
Overall status
Unknown status
Start date
March 28, 2022
Completion date
January 26, 2024
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hypercapnic respiratory failure, chronic obstructive pulmonary disease, health-related quality of life, nasal high flow, obesity hypoventilation syndrome (ohs)